Hepatology

Top Story

Suboptimal response in HCV genotype 4 in Egypt driven by noncompliance

April 29, 2016

Suboptimal treatment response in chronic HCV genotype 4 in Egypt was driven primarily by noncompliance as well as gaps in the health care system that lead to treatment discontinuation, according to recent findings published in Journal of Viral Hepatitis.

“In Egypt, the national program for HCV treatment has provided a rich pool of data which have led to the conduction of large population-based studies,” the researchers wrote. “This is one of the largest studies examining HCV treatment effectiveness.”

In the Journals

Physicians who do not certify more likely to receive disciplinary actions

April 28, 2016
An analysis of data sets found that 95% of internal medicine residents achieve certification through the American Board of Internal Medicine, according to findings…
Meeting News CoverageVideo

Zepatier shows high efficacy in hard-to-treat HCV populations

April 28, 2016
BARCELONA — In this exclusive video interview at the International Liver Congress, Jan Sperl, MD, of the Institute for Clinical and Experimental Medicine, Prague…
Meeting News Coverage

Pediatric LT recipients show increased odds for survival post-transplant

April 28, 2016
BARCELONA — Children who underwent liver transplantation lived for 20 years or more post-transplant, according to data presented at the International Liver…
In the Journals

Mothers receive inadequate systemic HBV care following pregnancy

April 27, 2016
A majority of mothers with chronic hepatitis B virus infection post-pregnancy received inadequate care, especially in terms of timely liver function test measurements…
More News Headlines »
CME Video

Case Challenges in Pediatric Fatty Liver: What to Look For and When to Refer

This activity is supported by an educational grant from Synageva BioPharma Corp.

Non-alcoholic fatty liver disease (NAFLD) is characterized by excess fat deposition in the liver due to causes other…
More »
Video
Meeting News Coverage

Zepatier shows high efficacy in hard-to-treat HCV populations

April 28, 2016
More »
Featured
Highlights from International Liver Congress

Highlights from International Liver Congress

Current Issues Current Issues
View the Current Issue
HCV Next
morganatic-roan